Identification of amino acids involved in histamine potentiation of GABAA receptors

Frontiers in Pharmacology

Volumn 6, Issue MAY, 2015, Pages

  Thiel, Ulrike ^a   Platt, Sarah J ^a   Wolf, Steffen ^a,b   Hatt, Hanns ^a   Gisselmann, Günter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Chinese Academy of Sciences   (China)

Author keywords

GABAAR; Histamine; Modulation; Potentiation; Salt bridge; Site directed mutagenesis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINO ACID; HISTAMINE; PROPOFOL;

4 AMINOBUTYRIC ACID METABOLISM; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; MOLECULAR INTERACTION; NONHUMAN; OOCYTE; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; VOLTAGE CLAMP TECHNIQUE; XENOPUS LAEVIS;

EID: 84930642855     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00106     Document Type: Article

References (44)

1. Amin, J., and Weiss, D. S. (1993). GABAA receptor needs two homologous domains of the β-subunit for activation by GABA but not by pentobarbital. Nature 366, 565-569. doi: 10.1038/366565a0.
2. Bekkers, J. M. (1993). Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science 261, 104-106. doi: 10.1126/science.8391168.
3. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci. 6, 565-575. doi: 10.1038/nrn1703.
4. Bianchi, M. T., Clark, A. G., and Fisher, J. L. (2011). The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors. Neuropharmacology 61, 747-752. doi: 10.1016/j.neuropharm.2011.05.020.
5. Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., et al. (2014). SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252-W258. doi: 10.1093/nar/gku340.
6. Bureau, M. H., and Olsen, R. W. (1991). Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro. Eur. J. Pharmacol. 207, 9-16. doi: 10.1016/S0922-4106(05)80031-8.
7. Chang, Y., and Weiss, D. S. (1999). Allosteric-activation mechanism of the α1β2γ2γ-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine. Biophys. J. 77, 2542-2551. doi: 10.1016/S0006-3495(99)77089-X.
8. Congreve, M., Carr, R., Murray, C., and Jhoti, H. (2003). A rule of three for fragment-based lead discovery. Drug Discov. Today 8, 876-877. doi: 10.1016/S1359-6446(03)02831-9.
9. Edgar, R. (2004). MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797. doi: 10.1093/nar/gkh340.
10. Galzi, J. L., Bertrand, S., Corringer, P. J., Changeux, J. P., and Bertrand, D. (1996). Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J. 15, 5824-5832.
11. Grobin, A. C., Matthews, D. B., Devaud, L. L., and Morrow, A. L. (1998). The role of GABAA receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl.) 139, 2-19. doi: 10.1007/s002130050685.
12. Haas, H. L., Sergeeva, O. A., and Selbach, O. (2008). Histamine in the nervous system. Physiol. Rev. 88, 1183-1241. doi: 10.1152/physrev.00043.2007.
13. Heckman, K. L., and Pease, L. R. (2007). Gene splicing and mutagenesis by PCR-driven overlapextension. Nat. Protoc. 2, 924-932. doi: 10.1038/nprot.2007.132.
14. Hosie, A. M., Dunne, E. L., Harvey, R. J., and Smart, T. G. (2003). Zinc-mediated inhibition of GABAA receptors: discrete binding sites underlie subtype specificity. Nat. Neurosci. 6, 362-369. doi: 10.1038/nn1030.
15. Jurd, R., Arras, M., Lambert, S., Drexler, B., Siegwart, R., Crestani, F., et al. (2003). General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit. FASEB J. 17, 250-252.
16. Kim, H., and McDonald, R. L. (2003). An n-terminal histidine is the primary determinant of a subunit-dependent Cu2+ sensitivity of αβ3γ2L GABAA receptors. Mol. Pharmacol. 64, 1145-1152. doi: 10.1124/mol.64.5.1145.
17. Kletke, O., Sergeeva, O. A., Lorenz, P., Oberland, S., Meier, J. C., Hatt, H., et al. (2013). New insights in endogenous modulation of ligand-gated ion channels: histamine is an inverse agonist at strychnine sensitive glycine receptors. Eur. J. Pharmacol. 710, 59-66. doi: 10.1016/j.ejphar.2013.04.002.
18. Krasowski, M. D., Nishikawa, K., Nikolaeva, N., Lin, A., and Harrison, N. L. (2001). Methionine 286 in transmembrane domain 3 of the GABAA receptor β subunit controls a binding cavity for propofol and other alkylphenol general anesthetics. Neuropharmacology 41, 952-964. doi: 10.1016/S0028-3908(01)00141-1.
19. Kufareva, I., Rueda, M., Katritch, V., Stevens, R. C., and Abagyan, R. (2011). Status of GPCR modeling and docking as reflected by community-wide GPCR dock 2010 assessment. Structure 19, 1108-1126. doi: 10.1016/j.str.2011.05.012.
20. Laha, K. T., and Wagner, D. A. (2011). A state-dependent salt-bridge interaction exists across the β/α intersubunit interface of the GABAA receptor. Mol. Pharmacol. 79, 662-671. doi: 10.1124/mol.110.068619.
21. Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006). Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J. Neurosci. 26, 11599-11605. doi: 10.1523/JNEUROSCI.3467-06.2006.
22. McDonald, R. L., and Olsen, R. W. (1994). GABAA receptor channels. Annu. Rev. Neurosci. 17, 569-602. doi: 10.1146/annurev.ne.17.030194.003033.
23. Miller, P. S., and Aricescu, A. R. (2014). Crystal structure of a human GABAA receptor. Nature 512, 270-275. doi: 10.1038/nature13293.
24. Newell, J. G., McDevitt, R. A., and Czajkowski, C. (2004). Mutation of Glutamate 155 of the GABAA Receptor β2 subunit produces a spontaneously open channel: a trigger for channel activation. J. Neurosci. 24, 11226-11235. doi: 10.1523/JNEUROSCI.3746-04.2004.
25. Nutt, D. (2006). GABAA receptors: subtypes, regional distribution, and function. J. Clin. Sleep Med. 2, 7-11.
26. Olsen, R. W., and Sieghart, W. (2008). International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 60, 243-260. doi: 10.1124/pr.108.00505.
27. Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., and Sperk, G. (2000). GABAA receptors: immuncytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815-850. doi: 10.1016/S0306-4522(00)00442-5.
28. Reynolds, D. S., Roshal, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., et al. (2003). Sedation and anesthesia mediated by distinct GABAA receptor isoforms. J. Neurosci. 23, 8608-8617.
29. Rudolph, U., and Knoflach, F. (2011). Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat. Rev. Drug Discov. 10, 685-697. doi: 10.1038/nrd3502.
30. Saras, A., Gisselmann, G., Vogt-Eisele, A. K., Erlkamp, K. S., Kletke, O., Pusch, H., et al. (2008). Histamine action on vertebrate GABAA receptors; direct channel gating and potentiation of GABA responses. J. Biol. Chem. 283, 10470-10475. doi: 10.1074/jbc. M709993200.
31. Schneider, M., Wolf, S., Schlitter, J., and Gerwert, K. (2011). The structure of active opsin as a basis for identification of GPCR agonists by dynamic homology modelling and virtual screening assays. FEBS Lett. 585, 3587-3592. doi: 10.1016/j.febslet.2011.10.027.
32. Schrödinger, LLC. (2010). The PyMOL Molecular Graphics System, Version~1.3r1.
33. Schuttelkopf, A. W., and van Aalten, D. M. (2004). PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363. doi: 10.1107/S0907444904011679.
34. Sergeeva, O. A., Kletke, O., Kragler, A., Poppek, A., Fleischer, W., Schubring, S. R., et al. (2010). Fragrant dioxane derivates identify β1-subunit-containing GABAA receptors. J. Biol. Chem. 285, 23985-23993. doi: 10.1074/jbc. M110.103309.
35. Siegwart, R., Jurd, R., and Rudolph, U. (2002). Molecular determinants for the action of general anesthetics at recombinant α2β3γ2γ-aminobutyric acidA receptors. J. Neurochem. 80, 140-148. doi: 10.1046/j.0022-3042.2001.00682.x.
36. Sigel, E., Baur, R., Kellenberger, S., and Malherbel, P. (1992). Point mutations affecting antagonist affinity and agonist dependent gating of GABAA receptor channels. EMBO J. 11, 2017-2023.
37. Simon, J., Wakimoto, H., Fujita, N., Lalande, M., and Barnard, E. A. (2004). Analysis of the set of GABAA receptor genes in the human genome. J. Biol. Chem. 279, 41422-41435. doi: 10.1074/jbc. M401354200.
38. Te Heesen, H. T., Schlitter, A. M., and Schlitter, J. (2007). Empirical rules facilitate the search for binding sites on protein surfaces. J. Mol. Graph. Model. 25, 671-679. doi: 10.1016/j.jmgm.2006.05.005.
39. The UniProt Consortium. (2013). Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42, D191-D198. doi: 10.1093/nar/gkt1140.
40. Thompson, S. A., Whiting, P. J., and Wafford, K. A. (1996). Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br. J. Pharmacol. 117, 521-527. doi: 10.1111/j.1476-5381.1996.tb15221.x.
41. Trott, O., and Olson, A. J. (2010). AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455-461.
42. Williams, C. A., Bell, S. V., and Jenkins, A. (2010). A residue in loop 9 of the β2-subunit stabilizes the closed state of the GABAA receptor. J. Biol. Chem. 285, 7281-7287. doi: 10.1074/jbc. M109.050294.
43. Wolf, S., Böckmann, M., Höweler, U., Schlitter, J., and Gerwert, K. (2008). Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site. FEBS Lett. 582, 3335-3342. doi: 10.1016/j.febslet.2008.08.022.
44. Yip, G. M. S., Chen, Z. W., Edge, C. J., Smith, E. H., Dickinson, R., Hohenester, E., et al. (2013). A propofol binding site on mammalian GABAA receptors identified by photolabeling. Nat. Chem. Biol. 9, 715-720. doi: 10.1038/nchembio.1340.